Literature DB >> 20945037

Prognosis of colorectal cancer with liver metastasis: value of a prognostic index.

Y Wang1, Y F Liu, Y Cheng, D H Yi, P Li, W Q Song, D Z Fu, X Wang.   

Abstract

The objective of the present study was to explore the factors related to the prognosis of colorectal cancer (CRC) and to establish a prognostic model for the selection of patients who might benefit from hepatic resection for metastatic CRC. A total of 293 patients undergoing liver resection for metastatic CRC (172 males and 80 females ranging in age from 26 to 80 years) were selected and clinical, pathological and outcome data were examined in this retrospective study. The prognostic index (PI) of the patients was calculated on the basis of results of multivariate analysis. Patients were stratified into different groups, with survival curves projected according to PI. The 1-, 3-, and 5-year overall survival rates were 58.3, 26.4, and 11.3%, respectively. Univariate analysis indicated that degree of primary tumor differentiation, resection margin, preoperative carcinoembryonic antigen (CEA) level, number of liver metastases, and resection of liver metastases were associated with prognosis (P < 0.05). In multivariate analysis, the last three factors were found to be independent prognostic factors. The resection of liver metastases was a favorable factor. Patients were classified into three groups according to PI, which differed significantly in survival rate (P < 0.05). The individual survival rate was evaluated based on PI. Resection of hepatic colorectal metastases may produce long-term survival and cure. The proposed PI was easy to use, was highly predictive of patient outcome, and permitted categorization of patients into treatment groups.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20945037     DOI: 10.1590/s0100-879x2010007500103

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  9 in total

1.  An overview of colorectal cancer survival rates and prognosis in Asia.

Authors:  Bijan Moghimi-Dehkordi; Azadeh Safaee
Journal:  World J Gastrointest Oncol       Date:  2012-04-15

2.  Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer.

Authors:  Ying Chen; Honggang Xiang; Yingfan Zhang; Jiejun Wang; Guanzhen Yu
Journal:  Clin Exp Metastasis       Date:  2015-04-14       Impact factor: 5.150

Review 3.  Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes.

Authors:  Alyson L Mahar; Carolyn Compton; Susan Halabi; Kenneth R Hess; Martin R Weiser; Patti A Groome
Journal:  J Surg Oncol       Date:  2017-08-02       Impact factor: 3.454

4.  Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).

Authors:  Christos Dervenis; Evaghelos Xynos; George Sotiropoulos; Nikolaos Gouvas; Ioannis Boukovinas; Christos Agalianos; Nikolaos Androulakis; Athanasios Athanasiadis; Christos Christodoulou; Evangelia Chrysou; Christos Emmanouilidis; Panagiotis Georgiou; Niki Karachaliou; Ourania Katopodi; Panteleimon Kountourakis; Ioannis Kyriazanos; Thomas Makatsoris; Pavlos Papakostas; Demetris Papamichael; George Pechlivanides; Georgios Pentheroudakis; Ioannis Pilpilidis; Joseph Sgouros; Paris Tekkis; Charina Triantopoulou; Maria Tzardi; Vassilis Vassiliou; Louiza Vini; Spyridon Xynogalos; Nikolaos Ziras; John Souglakos
Journal:  Ann Gastroenterol       Date:  2016-06-03

5.  CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.

Authors:  J L Hu; W Wang; X L Lan; Z C Zeng; Y S Liang; Y R Yan; F Y Song; F F Wang; X H Zhu; W J Liao; W T Liao; Y Q Ding; L Liang
Journal:  Mol Cancer       Date:  2019-05-07       Impact factor: 27.401

6.  Long Non-Coding RNA TTN-AS1 Promotes the Proliferation and Invasion of Colorectal Cancer Cells by Activating miR-497-Mediated PI3K/Akt/mTOR Signaling.

Authors:  Zhenhua Cui; Bingbing Han; Xianren Wang; Zhiwen Li; Jianxin Wang; Yanfeng Lv
Journal:  Onco Targets Ther       Date:  2019-12-27       Impact factor: 4.147

7.  Not All Kirsten Rat Sarcoma Viral Oncogene Homolog Mutations Predict Poor Survival in Patients With Unresectable Colorectal Liver Metastasis.

Authors:  Zhizun Lin; Yi Liu; Shaoxin Cai; Changshun Yang; Liyuan Zhou; Weihua Li
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

8.  Contrast MR-Based Radiomics and Machine Learning Analysis to Assess Clinical Outcomes following Liver Resection in Colorectal Liver Metastases: A Preliminary Study.

Authors:  Vincenza Granata; Roberta Fusco; Federica De Muzio; Carmen Cutolo; Sergio Venanzio Setola; Federica Dell' Aversana; Alessandro Ottaiano; Antonio Avallone; Guglielmo Nasti; Francesca Grassi; Vincenzo Pilone; Vittorio Miele; Luca Brunese; Francesco Izzo; Antonella Petrillo
Journal:  Cancers (Basel)       Date:  2022-02-22       Impact factor: 6.639

9.  Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC).

Authors:  Carl Christoph Schimanski; Stefan Kasper; Susanna Hegewisch-Becker; Jan Schröder; Friedrich Overkamp; Frank Kullmann; Wolf Otto Bechstein; Matthias Vöhringer; Robert Öllinger; Florian Lordick; Volker Heinemann; Michael Geißler; Armin Schulz-Abelius; Helga Bernhard; Michael R Schön; Richard Greil; Peter Galle; Hauke Lang; Irene Schmidtmann; Markus Moehler
Journal:  Oncoimmunology       Date:  2020-08-23       Impact factor: 8.110

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.